Patient and Consumer Health Research Platforms in the US 2026

Last updated: 23 September 2026

Quick Answer: Patient research platforms that run interviews include Alchemic, Blue Lens Research, Dscout, Health Union, M3 Global Research, MediTalk and Rare Patient Voice. CLINIGMA and Cethos cover regulated trial and translation interviews. Choose by whether the study touches protected health information, and by the channel your patients will actually answer on.

A 2020 analysis of Medicare beneficiaries found that 38 percent of Americans aged 65 or older were not ready for a telemedicine video visit. They are core respondents for arthritis, diabetes and caregiving research, so the interview channel decides whether a study hears them.

Key takeaways

• Patient and consumer-health research is a different buy from HCP and pharma research.
• The ten platforms split into AI-moderated interview platforms, patient panels and communities, and regulated specialists.
• HIPAA binds covered entities and their business associates, not every health study; state laws can still apply.
• Video-first fieldwork under-reaches older patients, so the channel shapes the sample.
• Alchemic fits consumer-health interviews at scale by phone and WhatsApp; a HIPAA-bound hospital study or a clinical trial belongs with a specialist.

Patient Research and HCP Research Are Different Buys

Patient and consumer-health research interviews the people who live with a condition or buy health products: patients, caregivers and shoppers. HCP and pharma research interviews physicians, nurses and pharmacists about prescribing and clinical practice. Panels, incentives and rules all differ, so strength in one is no proof of strength in the other.

Many healthcare market research companies sell both, and a physician panel with a patient add-on is still built around the physician. Three kinds of work sit on the patient side of the line:

1. Patient experience research for hospitals, clinics and digital health services.
2. Consumer-health research for brands selling over-the-counter medicines, supplements, personal care, devices and wellness apps.
3. Patient journey and caregiver research for marketers who need the lived experience of a condition, not a clinical endpoint.

HCP research, KOL interviews and clinician-led medical interviews are out of scope here, as is any interview that is itself trial evidence.

Which Platforms Interview Patients and Caregivers

Of the ten platforms, four field AI-moderated interviews, four supply patients through panels or communities, and two run regulated, human-led interviews for trials and translated questionnaires.

How This Guide Evaluates Patient Research Platforms

Each platform was read on its own website on 23 September 2026, and every cell below comes from that page. Five things were checked:

1. Who it interviews: patients, caregivers, consumers or clinicians.
2. Interview modes: AI-moderated or human-led, and on which channel.
3. Recruitment: its own panel, your list, or both.
4. Compliance stated on its own site: HIPAA, HITRUST, SOC 2, GDPR, ICH-GCP.
5. Best-fit study: given in each heading below.

No platform was scored on interview quality, because no independent benchmark of it exists for health research.

Comparison at a Glance

Rows are sorted alphabetically by platform name. "Not stated" means the page reviewed makes no claim either way.

If your study is consumer-health work that has to reach patients beyond the video-comfortable, AI phone research is the route worth testing first.

1. Alchemic: Best for Consumer-Health Interviews by Phone and WhatsApp

Alchemic runs end-to-end consumer research at scale, and the respondent chooses the channel: a web link, a WhatsApp-native interview with no link and no app, answered in text or voice notes, or an outbound AI phone call with consent captured on the first turn and every call recorded and searchable. The service publishes 57+ languages including Hindi, Tamil and Telugu, and recruitment is managed fieldwork or bring your own across 14 markets including the USA and the UK. A 200-interview qualitative study runs brief to live dashboard in 3 days, against 4 to 6 weeks traditionally. Its WhatsApp and phone pages list Even Health among clients, beside a roster that includes Unilever and Mars.

Limit: its published posture is DPDP-aligned consent, configurable retention and customer data never used for model training, with SOC 2 Type II in progress. The pages reviewed state no HIPAA or BAA terms, so a covered entity sending patient records should start elsewhere.

2. Autentic AI: Best for Fast Consumer Reads Without Health Records

Autentic AI finds participants, runs AI-moderated in-depth interviews by voice or inside a product, and returns themes, quotes and emotion reads in hours. It interviews consumers, patients and industry experts, lists concept, pricing and messaging work among its use cases, and documents revocable consent for every interview. It states GDPR compliance, with ISO 27001 in progress.

Limit: its homepage lists a Health & Pharma sector for patient and HCP voice but makes no HIPAA claim there. It fits a supplement brand testing claims language better than a clinic studying its own patients.

3. Blue Lens Research: Best for Health-System Patient Experience

Blue Lens Research is built for healthcare organizations. Its AI moderator runs text, voice and video interviews and masks the 18 HIPAA identifiers during the interview itself, under the Safe Harbor method. It states HIPAA-compliant infrastructure, SOC 2 Type II certification, BAA readiness and HITRUST CSF alignment, supports 50+ languages, maps themes to HCAHPS domains, and routes adverse-event mentions to a safety team.

Limit: recruitment runs through the organization's own patient portal, email or SMS. It suits a hospital that owns its patient list, less so a brand that needs to find patients it has never met.

4. Cethos: Best for Cognitive Debriefing of Translated Questionnaires

Cethos runs linguistic validation. When a patient questionnaire is translated, its interviewers check that patients understand every item the same way in every language. Sessions run one-to-one or in small groups by video or phone, usually 30 to 90 minutes, in 150+ study languages for sponsors and CROs.

Limit: this is a narrow, regulated service. It answers "does this translated item mean the same thing", not "why do patients stop taking the product".

5. CLINIGMA: Best for In-Trial Patient Interviews

CLINIGMA specializes in patient interviews inside clinical trials, run to ICH-GCP standards, to support patient-focused drug development and regulatory submissions. It also runs real-world and post-marketing interviews and focus groups, and states 35+ active interview countries and 100+ interview languages.

Limit: it is built for trial sponsors. A consumer-health brand asking about packaging or pharmacy experience is paying for rigor the decision does not need.

6. Dscout: Best for In-Context Patient Journeys and Telehealth UX

Dscout pairs its own pool of verified participants, called Scouts, with the option to invite your own users, and runs diary studies, mobile live interviews, usability tests and AI-moderated studies. Its healthcare page describes hospital systems tracking the patient journey from scheduling to discharge and providers studying telehealth experience, and states HIPAA compliance, HITRUST certification, ISO 27001 and SOC 2.

Limit: Scouts take part through the Dscout mobile app, so the pool leans toward people comfortable with an app-based study.

7. Health Union: Best for Patient Journey and Caregiver Insight

Health Union runs 125+ condition-specific online communities and draws research from non-panelist patients and caregivers engaged over 15+ years. Its insights team reports 60+ therapeutic areas and 75+ custom projects a year, including patient journey mapping, patient advisory boards, and message testing.

Limit: the research sits beside a DTC advertising and HCP activation business, and the offer integrates HCP voices. Buyers who need patient-only work should say so in the brief.

8. M3 Global Research: Best for Diagnosed-Patient Studies With Hard Quotas

M3 Global Research runs a patient panel built for healthcare research rather than a repurposed consumer panel, and states 700+ projects, 69,000+ patient completes and 153 unique conditions. It builds custom patient communities for copy testing and tracking, and uses its HCP panel and advocacy partners to refer patients.

Limit: the published work leans quantitative; one case, 100 US patients with seasonal affective disorder, reports incidence at 27 percent against an estimated 40 percent. Budget for top-ups.

9. MediTalk: Best for Human-Moderated Patient Sessions

MediTalk, run by Medicys, recruits patients and caregivers for Zoom interviews, surveys, online bulletin boards, daily diaries and wearable studies. It anonymizes what participants share before it reaches the researcher, pays incentives usually within 48 hours, and states membership of BHBIA, EphMRA, ISPOR and ESOMAR.

Limit: interviews run over password-protected Zoom, which assumes a respondent who can join a video call.

10. Rare Patient Voice: Best for Rare and Low-Incidence Conditions

Rare Patient Voice, a Konovo company, recruits patients and caregivers at awareness walks, disease meetings and conferences, through advocacy groups and on social media, and publishes counts by condition for nine countries, including the US, the UK, Canada and Australia. It reports typical response of 50 percent for non-cancer studies and up to 20 percent for cancer studies.

Limit: the published counts are thin at the rarest end, with single-digit totals for several US syndromes, so feasibility has to be checked condition by condition.

When HIPAA Applies to a Research Vendor

HIPAA applies to covered entities and their business associates, and to nobody else. A covered entity is a health plan, a health care clearinghouse, or a health care provider that transmits health information electronically in a standard transaction. A research vendor comes under HIPAA when it handles protected health information for one.

The HHS guidance on covered entities and business associates covers both halves. A covered entity must have a written contract with any business associate setting out what it may do with the data, and business associates are directly liable for parts of the Rules. An entity that meets neither definition does not have to comply.

Three situations cover most patient research:

1. A hospital or health plan studies its own patients or members. A vendor touching their records is a business associate, so ask for a signed business associate agreement before fieldwork.
2. A consumer-health brand interviews its buyers or a recruited panel. The brand is usually not a covered entity, so HIPAA does not attach, though other privacy laws can.
3. A study uses data a covered entity holds. The HHS research guidance sets the main routes: the patient's authorization, an IRB or Privacy Board waiver, or de-identified data, which a covered entity may always use.

A vendor's HIPAA badge does not make a study compliant; the data flow and the contract do, so confirm with counsel which situation applies.

Consent and Sensitivity in Health Interviews

Health interviews need two things beyond ordinary consent:

1. A plain statement of what happens to health details.
2. A route to a human when a topic can cause distress.

No automated moderator has been validated as a distress detector, so the study design has to supply the safety net.

Alchemic's consent and disclosure guidance draws the working boundary. Health conditions, bereavement and any topic where distress is foreseeable route to a human moderator, or to a human wave in a split design. Product experience, pharmacy service, packaging and category habits suit AI moderation. Most consumer-health guides carry both, so mark which sections go where.

Consent also has to cover data HIPAA never touches. Washington's My Health My Data Act, signed in April 2023, is described by the state Attorney General as the first privacy law in the country to protect personal health data outside HIPAA. It counts health inferences drawn from non-health data as consumer health data.

Four checks belong in every consumer-health study before launch:

1. Say in the first message what health details will be asked and who will see them.
2. Offer a skip on every health question, and say so up front.
3. Name a human contact the participant can reach during and after the interview.
4. Delete or de-identify condition details the analysis does not need.

Reaching Patients by Phone and WhatsApp

The channel decides which patients a study hears from. A video link reaches the digitally comfortable; a phone call or a WhatsApp message reaches more of the older and less connected patients who dominate most chronic conditions.

Lam and colleagues, in JAMA Internal Medicine, analyzed 2018 National Health and Aging Trends Study data on 4,525 community-dwelling Medicare beneficiaries. An estimated 13 million older Americans, 38 percent, were not ready for video visits, mostly through inexperience with technology, and 72 percent of those 85 or older met the unreadiness criteria. For telephone visits the unready share fell to 20 percent, and only 1 percent had no phone.

A review by Novick in Research in Nursing and Health found little evidence that telephone interviews yield lower-quality qualitative data, and noted the phone may help respondents relax and disclose sensitive information.

Each channel carries its own rules: US research calls sit under the TCPA, covered in TCPA rules for AI phone research, and messaging needs opt-in, covered in recruiting and consenting respondents on WhatsApp. Respondents with no smartphone are covered in reaching respondents without smartphones.

Alchemic's WhatsApp interviews reach a caregiver in the app they already use, in text or voice notes, and its outbound AI calls reach a patient on any phone number in supported regions. One study can mix both, with the respondent choosing.

When Another Platform Is the Better Choice

A consumer research platform is the wrong tool for several patient studies.

• A hospital studying its own patients with record-linked data should start with Blue Lens Research or Dscout, which state HIPAA terms on their own sites; a covered entity needs that contract before patient data moves.
• An ultra-rare condition belongs with Rare Patient Voice or Health Union, which recruit through advocacy groups and condition communities.
• Evidence for a regulatory submission belongs with CLINIGMA, and a translated patient questionnaire with Cethos.
• A physician or pharmacist study belongs with an HCP panel, outside this guide.

How to Run a Trial Before You Sign

A paid pilot of 20 to 30 interviews tells you more than a demo. Run one short guide with two shortlisted platforms on the same patient profile, and compare five things:

1. Reach: who completed, and who dropped out by age, device and channel.
2. Data flow: where recordings sit, who sees identifiers, what the contract says.
3. Safety: what happened when a participant raised something distressing.
4. Evidence: whether each finding links to the exact quote or recording.
5. Turnaround: calendar days from signed brief to a readable output.

Keep the pilot topic in the product and service zone, so no untested distress protocol meets real patients.

What Still Needs a Clinician-Led Study

Symptom assessment, diagnosis, treatment decisions, trial safety reporting and anything that becomes regulatory evidence are clinical work, and clinician-led medical interviews are not what a consumer research platform, Alchemic included, sells.

In AI-moderated patient work, text and voice modes carry no facial signal. How much latitude a system has to leave its guide varies by tool, and none has been validated for clinical judgment. Patients who cannot consent for themselves need a caregiver or a clinical setting instead.

For consumer-health work on the right side of that line, once it has the client's brief, Alchemic designs and tailors the discussion guide to handle these risks before fielding, rather than leaving that work to the buyer. How AI and human moderation divide the rest is covered in AI against human moderated interviews.

Sources and Methodology

Platform facts come from each platform's own website, read on 23 September 2026; none was tested hands-on or paid for inclusion, and none is linked. External sources, each linked inline where its claim appears:

• HHS, Covered Entities and Business Associates: who must comply with HIPAA, and the business associate contract.
• HHS, Research (HIPAA Privacy Rule): authorization, waiver and de-identification routes for research.
• Washington State Attorney General, My Health My Data Act: health data protection outside HIPAA.
• Lam et al., JAMA Internal Medicine, 2020: video and phone unreadiness among US adults 65 and older.
• Novick, Research in Nursing and Health, 2008: telephone interviews in qualitative research.